Skip to content

Evaluation of the satiating and probiotic effect of goat cheese in volunteers on a weight control regimen: A randomized controlled trial

Evaluation of the satiating and probiotic effect of goat cheese in volunteers on a weight control regimen: A randomized controlled trial - NUTRICHEESE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
RPCEC
Registry ID
RPCEC00000462
Enrollment
20
Registered
2025-11-17
Start date
2025-11-19
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight and obesity

Interventions

Group A (Experimental): 80 g of goat cheese with lower content of fat three days a week for fourth weeks, prohibited consuming milk, yogurt, cheese. Group B (Control): 80 g of goat cheese with higher
Diet, Food, and Nutrition
goat cheese

Sponsors

Genomic Biotechnology Center – National Polytechnic Institute (IPN-Reynosa), Mexico
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Adults: Women and Men 2. Nationality of any kind 3. Body mass index =25 4. Age: 18–55 years 5. Clinically healthy 6. Subjects from any socioeconomic or cultural group 7. Able to be informed about the study and willing to accept and sign written informed consent prior to the study 8. Consume goat cheese

Exclusion criteria

Exclusion criteria: 1. Allergic and/or lactose intolerant 2. Type I or II diabetes 3. High blood pressure (defined as systolic blood pressure =140 or diastolic blood pressure =90 mmHg) 4. Cardiovascular disease, chronic kidney disease 5. Hyperlipidemia 6. Alcoholism and/or drug dependence 7. Smoker (>10 cigarettes per day) 8. Women who are pregnant or breastfeeding 9. Undergoing any medical treatment 10. Use of anorectic agents that act on the adrenergic, serotonergic, and adrenergic/serotonergic pathways. 11. Use of medications or supplements. 12. Insufficient motivation, as assessed by the interview, to remain in the clinical trial. 13. The volunteer no longer wishes to participate in the study 14. Inability to comply with the instructions of the investigation

Design outcomes

Primary

MeasureTime frame
Acylated ghrelin. Measurement time: At the beginning and 4 weeks (before breakfast, at minute 30 and 120 after finishing breakfast).

Secondary

MeasureTime frame
Anthropometric measurements and indexs: Weight (in Kg), Waist circumference (in cm), Abdominal circumference (in cm), Hip circumference (in cm), Waist-hip ratio (waist circumference/hip circumference in cm), Body Mass Index-BMI (Weight/(Height*Height). (Weight measured in Kg and height in m) measurement time: At baseline, at 2 and 4 weeks. Satiety (VAS) Measurement time: before breakfast, at minute 30 and 120 after finishing breakfast. Bacterial diversity Measurement time: at baseline, at 2, 3 and 4 weeks. Plasma lipid profile (Total cholesterol, Triglycerides, very low, low and high density lipoproteins (values in mg/dL)), measurement time: At baseline and 4 weeks. Nutrigenetic and nutrigenomic analysis measurement time: At baseline and 4 weeks. HOMA-IR index, measurement time: At baseline and 4 weeks.

Countries

Mexico

Contacts

Public ContactDiana Vela Vasquez

Genomic Biotechnology Center – National Polytechnic Institute

diana.w@outlook.com

Outcome results

None listed

Source: RPCEC (via WHO ICTRP) · Data processed: Apr 4, 2026